| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |